SLXN · Silexion Therapeutics Corp
AI read · Bad for SLXN
The AI's read
This gives Silexion a chance to keep trading on Nasdaq. Yet it has to raise money twice, keep its closing share price at or above $1 for 10 trading days, and meet several deadlines. Missing a requirement could end its Nasdaq listing, so the relief is limited.